Multi-antibiotic Resistance Clinical Trial
Official title:
Pathway From Functional Disability to Antimicrobial Resistance in Nursing Home Residents
Multidrug-resistant organisms (MDROs) are endemic in nursing homes (NHs) with prevalence rates surpassing those in hospitals. The aim of the study is to design and evaluate the effectiveness of a multi-component intervention to reduce new acquisition of MDROs in NH residents. The intervention will incorporate resident-level, environmental, and caregiver based strategies. Using a cluster-randomized study design, three NHs will be randomized to the intervention group and three to the control group. Control NHs will be allowed to continue standard infection prevention practices. Nursing homes will serve as the unit of allocation. Analyses will be performed both at the resident and the cluster level. The primary outcomes of the study are reduction in MDRO prevalence, and reduction in new MDRO acquisition .
The NH intervention will incorporate resident-level, environmental, and caregiver based strategies, including: a. Standard precautions and hand hygiene for care of all residents. Enhanced barrier precautions including hand hygiene, glove use, and gown use for healthcare workers (HCW) when providing activities of daily living (ADL) assistance for residents at highest-risk (caregiver intervention); b. Hand hygiene education to residents and families (resident-level intervention); c. Standardized bathing practices including using chlorhexidine-based cloths to reduce resident MDRO colonization (resident-level intervention); d. Standardized environmental protocol and education to reduce contamination on inanimate objects and surfaces (environmental intervention); e. Feedback monthly of facility-level microbial data and new MDRO acquisition rates to infection preventionists, front-line healthcare personnel, and facility leadership (facility intervention). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
| Recruiting |
NCT04335383 -
Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies
|
||
| Recruiting |
NCT04181112 -
Fecal Transplant for MDRO Decolonization
|
N/A | |
| Completed |
NCT05048693 -
Use of New Antibiotics in Sweden
|
||
| Completed |
NCT05897801 -
Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO
|
||
| Completed |
NCT04212130 -
Can Environmental Cleanliness be Assessed by BCA (Bicinchoninic Acid) Method
|
N/A | |
| Completed |
NCT05100407 -
Factors Impacting the Prevalence of MDR Bacteria
|
||
| Completed |
NCT05549427 -
Ventilator Associated Pneumonia by Multi-Drug Resistant Organism
|
||
| Not yet recruiting |
NCT06370299 -
Screening of Multidrug Resistant Bacteria, and the Clinical Implication for the Patient
|
||
| Recruiting |
NCT06148480 -
Perinatal Transmission of MDR Bacteria
|
||
| Recruiting |
NCT04995133 -
Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs.
|
Phase 4 | |
| Recruiting |
NCT03921645 -
Use of Aaerosol Combined With Intravenous Antibiotics for the Treatment of Multidrug Resistant GNB Pneumonia
|
N/A | |
| Completed |
NCT06199141 -
Multi-drug Resistant Gram-negative Bacteria and Veno-venous Extracorporeal Membrane Oxygenation (ECMO)
|
||
| Recruiting |
NCT04759001 -
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05791396 -
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
|
Phase 1/Phase 2 | |
| Terminated |
NCT02906774 -
Fecal Transplant for MDR Pathogen Decolonization
|
||
| Recruiting |
NCT06036628 -
Resistant Bacteria in Children in France
|